BRISTOL, Tenn., Feb. 2 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) today announced that a live audio webcast of its presentation
scheduled for Tuesday, February 7, 2006, at 1:40 p.m., Eastern Standard Time,
at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device
Conference at The Grand Hyatt in New York, New York may be accessed via the
internet. Interested persons may access the webcast on the King
Pharmaceuticals website at http://www.kingpharm.com/web_casts.asp. After the
event, a replay of the webcast may be accessed through Monday, February 20,
2006 at the same URL.
About King Pharmaceuticals
King, headquartered in Bristol, Tennessee, is a vertically integrated
branded pharmaceutical company. King, an S&P 500 Index company, seeks to
capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
Forward-looking Statements
This release contains forward-looking statements which reflect
management's current views of future events and operations, including, but not
limited to, statements pertaining to the anticipated audio webcast of the
Company's presentation on February 7, 2006. These forward-looking statements
involve certain significant risks and uncertainties, and actual results may
differ materially from the forward-looking statements. An important factor
which may cause results to differ is whether King is able to webcast the audio
portion of the presentation on February 7, 2006 as currently planned. King
does not undertake to publicly update or revise any of its forward-looking
statements even if experience or future changes show that the indicated
results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
http://www.kingpharm.com/web_casts.asp
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Sr.
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
